{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:26:58Z","timestamp":1757622418679,"version":"3.44.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Shenzhen\u00a0Key\u00a0Medical\u00a0Discipline, Shenzhen\u00a0Key\u00a0Medical\u00a0Discipline\u00a0Construction\u00a0Fund","award":["SZXK021"],"award-info":[{"award-number":["SZXK021"]}]},{"name":"Shenzhen Municipal Government\u2019s \u201cThree Major Projects in Medical and Health Care\u201d","award":["SZSM202201024"],"award-info":[{"award-number":["SZSM202201024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The carcinogenic effects of nitrate reduction to nitrite are well established, and nitrate has been closely linked to various diseases. However, research on its effects on the urinary system remains limited, and its association with PSA remains unclear. This study aims to investigate the relationship between urinary nitrate and PSA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We employed weighted generalized linear models, weighted univariate analysis, forest plots, weighted multivariable analysis, and generalized additive models (GAM) to investigate the relationship between urinary nitrate and PSA. Subgroup analyses were conducted to further validate the stability of this association across different groups. GAM was utilized to provide a more intuitive representation of the specific relationships between PSA and urinary nitrate.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>TPSA, FPSA, and the prostate specific antigen ratio (%, 4 ng\/mL\u2009\u2264\u2009TPSA\u2009\u2264\u200910 ng\/mL) showed negative correlations with urinary nitrate. After adjusting for confounders, only the prostate-specific antigen ratio maintained a significant negative association (\u03b2 = -632.7; 95% CI: -1094.9, -170.6; <jats:italic>P<\/jats:italic>\u2009=\u20090.011), while correlations with TPSA and FPSA were not statistically significant. A nonlinear relationship was observed, where urinary nitrate initially remained stable or changed minimally before gradually declining.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study identifies a negative correlation between urinary nitrate and the prostate-specific antigen ratio in individuals with gray-zone TPSA. These findings enhance our understanding of urinary nitrate\u2019s impact and may help reduce overtreatment in this population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12894-025-01878-5","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T04:29:23Z","timestamp":1754713763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between urinary nitrate and prostate specific antigen without prostatic disease: a cohort study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6269-5731","authenticated-orcid":false,"given":"Zhiyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enpu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4307-0526","authenticated-orcid":false,"given":"Guixiao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"issue":"1","key":"1878_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"1878_CR2","doi-asserted-by":"crossref","unstructured":"Force USPST, Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, Doubeni CA, Ebell M, Epling JW, editors. Jr.: Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2018, 319(18):1901\u20131913.","DOI":"10.1001\/jama.2018.3710"},{"issue":"2","key":"1878_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/cncr.21603","volume":"106","author":"AR Kristal","year":"2006","unstructured":"Kristal AR, Chi C, Tangen CM, Goodman PJ, Etzioni R, Thompson IM. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase. Cancer. 2006;106(2):320\u20138.","journal-title":"Cancer"},{"key":"1878_CR4","doi-asserted-by":"crossref","unstructured":"Liu Z, Chen C, Yu F, Yuan D, Wang W, Jiao K, Yang S, Zhang Y, Wang Y, Liu L et al. Association of Total Dietary Intake of Sugars with Prostate-Specific Antigen (PSA) Concentrations: Evidence from the National Health and Nutrition Examination Survey (NHANES), 2003\u20132010. Biomed Res Int 2021, 2021:4140767.","DOI":"10.1155\/2021\/4140767"},{"key":"1878_CR5","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.urology.2021.05.086","volume":"156","author":"A Mouzannar","year":"2021","unstructured":"Mouzannar A, Kuchakulla M, Blachman-Braun R, Nackeeran S, Becerra M, Nahar B, Punnen S, Ritch C, Parekh DJ, Gonzalgo ML. Impact of Plant-Based diet on PSA level: data from the National health and nutrition examination survey. Urology. 2021;156:205\u201310.","journal-title":"Urology"},{"issue":"6","key":"1878_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00345-019-02719-5","volume":"37","author":"GH Tan","year":"2019","unstructured":"Tan GH, Nason G, Ajib K, Woon DTS, Herrera-Caceres J, Alhunaidi O, Perlis N. Smarter screening for prostate cancer. World J Urol. 2019;37(6):991\u20139.","journal-title":"World J Urol"},{"issue":"4","key":"1878_CR7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1370\/afm.1539","volume":"11","author":"PK Han","year":"2013","unstructured":"Han PK, Kobrin S, Breen N, Joseph DA, Li J, Frosch DL, Klabunde CN. National evidence on the use of shared decision making in prostate-specific antigen screening. Ann Fam Med. 2013;11(4):306\u201314.","journal-title":"Ann Fam Med"},{"issue":"1","key":"1878_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/bju.14197","volume":"122","author":"C De Nunzio","year":"2018","unstructured":"De Nunzio C, Lombardo R, Nacchia A, Tema G, Tubaro A. Repeat prostate-specific antigen (PSA) test before prostate biopsy: a 20% decrease in PSA values is associated with a reduced risk of cancer and particularly of high-grade cancer. BJU Int. 2018;122(1):83\u20138.","journal-title":"BJU Int"},{"key":"1878_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00917-w","author":"J Luo","year":"2024","unstructured":"Luo J. Prostate cancer detection: achieving an optimal balance. Prostate Cancer Prostatic Dis. 2024. https:\/\/doi.org\/10.1038\/s41391-024-00917-w.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"8","key":"1878_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1093\/jnci\/djt017","volume":"105","author":"J Xia","year":"2013","unstructured":"Xia J, Gulati R, Au M, Gore JL, Lin DW, Etzioni R. Effects of screening on radical prostatectomy efficacy: the prostate cancer intervention versus observation trial. J Natl Cancer Inst. 2013;105(8):546\u201350.","journal-title":"J Natl Cancer Inst"},{"issue":"1\u20132","key":"1878_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0009-8981(98)00189-2","volume":"280","author":"K Yoshida","year":"1999","unstructured":"Yoshida K, Honda M, Sumi S, Arai K, Suzuki S, Kitahara S. Levels of free prostate-specific antigen (PSA) can be selectively measured by heat treatment of serum: free\/total-PSA ratios improve detection of prostate carcinoma. Clin Chim Acta. 1999;280(1\u20132):195\u2013203.","journal-title":"Clin Chim Acta"},{"issue":"16","key":"1878_CR12","doi-asserted-by":"publisher","first-page":"7085","DOI":"10.7314\/APJCP.2015.16.16.7085","volume":"16","author":"DM Bachour","year":"2015","unstructured":"Bachour DM, Chahin E, Al-Fahoum S. Human Kallikrein-2, prostate specific antigen and Free- prostate specific antigen in combination to discriminate prostate cancer from benign diseases in Syrian patients. Asian Pac J Cancer Prev. 2015;16(16):7085\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"1878_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<104::AID-CNCR15>3.0.CO;2-8","volume":"79","author":"C Stephan","year":"1997","unstructured":"Stephan C, Lein M, Jung K, Schnorr D, Loening SA. The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasia. Cancer. 1997;79(1):104\u20139.","journal-title":"Cancer"},{"issue":"2","key":"1878_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4103\/aja.aja_46_19","volume":"22","author":"J Liu","year":"2020","unstructured":"Liu J, Wang ZQ, Li M, Zhou MY, Yu YF, Zhan WW. Establishment of two new predictive models for prostate cancer to determine whether to require prostate biopsy when the PSA level is in the diagnostic Gray zone (4\u201310 Ng ml(-1)). Asian J Androl. 2020;22(2):213\u20136.","journal-title":"Asian J Androl"},{"issue":"1","key":"1878_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/13685538.2019.1578741","volume":"23","author":"A Erdogan","year":"2020","unstructured":"Erdogan A, Polat S, Keskin E, Turan A. Is prostate volume better than PSA density and free\/total PSA ratio in predicting prostate cancer in patients with PSA 2.5\u201310 ng\/ml?l and 10.1\u201330 ng\/ml?l? Aging Male. 2020;23(1):59\u201365.","journal-title":"Aging Male"},{"issue":"13","key":"1878_CR16","doi-asserted-by":"publisher","first-page":"e0249","DOI":"10.1097\/MD.0000000000010249","volume":"97","author":"Y Huang","year":"2018","unstructured":"Huang Y, Li ZZ, Huang YL, Song HJ, Wang YJ. Value of free\/total prostate-specific antigen (f\/t PSA) ratios for prostate cancer detection in patients with total serum prostate-specific antigen between 4 and 10 ng\/ml: A meta-analysis. Med (Baltim). 2018;97(13):e0249.","journal-title":"Med (Baltim)"},{"issue":"1","key":"1878_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2165\/00139709-200322010-00005","volume":"22","author":"TT Mensinga","year":"2003","unstructured":"Mensinga TT, Speijers GJ, Meulenbelt J. Health implications of exposure to environmental nitrogenous compounds. Toxicol Rev. 2003;22(1):41\u201351.","journal-title":"Toxicol Rev"},{"key":"1878_CR18","first-page":"v","volume":"94","author":"Humans","year":"2010","unstructured":"Humans, IWGotEoCRt. IARC monographs on the evaluation of carcinogenic risks to humans. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. IARC Monogr Eval Carcinog Risks Hum. 2010;94:v\u2013vii.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"11","key":"1878_CR19","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1289\/ehp.8043","volume":"113","author":"MH Ward","year":"2005","unstructured":"Ward MH, deKok TM, Levallois P, Brender J, Gulis G, Nolan BT, VanDerslice J. International society for environmental E: workgroup report: Drinking-water nitrate and health\u2013recent findings and research needs. Environ Health Perspect. 2005;113(11):1607\u201314.","journal-title":"Environ Health Perspect"},{"issue":"5","key":"1878_CR20","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1016\/j.clnu.2020.11.010","volume":"40","author":"F Hosseini","year":"2021","unstructured":"Hosseini F, Majdi M, Naghshi S, Sheikhhossein F, Djafarian K, Shab-Bidar S. Nitrate-nitrite exposure through drinking water and diet and risk of colorectal cancer: A systematic review and meta-analysis of observational studies. Clin Nutr. 2021;40(5):3073\u201381.","journal-title":"Clin Nutr"},{"issue":"4","key":"1878_CR21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00394-020-02332-y","volume":"60","author":"A Khodavandi","year":"2021","unstructured":"Khodavandi A, Alizadeh F, Razis AFA. Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis. Eur J Nutr. 2021;60(4):1707\u201336.","journal-title":"Eur J Nutr"},{"issue":"3","key":"1878_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.ajkd.2015.10.018","volume":"67","author":"X Chen","year":"2016","unstructured":"Chen X, Wei G, Jalili T, Metos J, Giri A, Cho ME, Boucher R, Greene T, Beddhu S. The associations of plant protein intake with All-Cause mortality in CKD. Am J Kidney Dis. 2016;67(3):423\u201330.","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"1878_CR23","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.chemosphere.2013.02.040","volume":"91","author":"RB Jain","year":"2013","unstructured":"Jain RB. Impact of pregnancy and other factors on the levels of urinary perchlorate, thiocyanate, and nitrate among females aged 15\u201344 years: data from National health and nutrition examination survey: 2003\u20132008. Chemosphere. 2013;91(7):882\u20137.","journal-title":"Chemosphere"},{"issue":"56","key":"1878_CR24","first-page":"1","volume":"1","author":"G Zipf","year":"2013","unstructured":"Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999\u20132010. Vital Health Stat. 2013;1(56):1\u201337.","journal-title":"Vital Health Stat"},{"key":"1878_CR25","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.12659\/MSM.914621","volume":"25","author":"FX Zhang","year":"2019","unstructured":"Zhang FX, Miao Y, Ruan JG, Meng SP, Dong JD, Yin H, Huang Y, Chen FR, Wang ZC, Lai YF. Association between nitrite and nitrate intake and risk of gastric cancer: A systematic review and Meta-Analysis. Med Sci Monit. 2019;25:1788\u201399.","journal-title":"Med Sci Monit"},{"issue":"7","key":"1878_CR26","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1002\/ijc.29901","volume":"138","author":"M Inoue-Choi","year":"2016","unstructured":"Inoue-Choi M, Sinha R, Gierach GL, Ward MH. Red and processed meat, nitrite, and Heme iron intakes and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Int J Cancer. 2016;138(7):1609\u201318.","journal-title":"Int J Cancer"},{"issue":"9","key":"1878_CR27","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/aje\/kwp280","volume":"170","author":"R Sinha","year":"2009","unstructured":"Sinha R, Park Y, Graubard BI, Leitzmann MF, Hollenbeck A, Schatzkin A, Cross AJ. Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the united States. Am J Epidemiol. 2009;170(9):1165\u201377.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"1878_CR28","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1289\/EHP191","volume":"124","author":"RR Jones","year":"2016","unstructured":"Jones RR, Weyer PJ, DellaValle CT, Inoue-Choi M, Anderson KE, Cantor KP, Krasner S, Robien K, Freeman LE, Silverman DT, et al. Nitrate from drinking water and diet and bladder cancer among postmenopausal women in Iowa. Environ Health Perspect. 2016;124(11):1751\u20138.","journal-title":"Environ Health Perspect"},{"issue":"5","key":"1878_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/EDE.0000000000000647","volume":"28","author":"RR Jones","year":"2017","unstructured":"Jones RR, Weyer PJ, DellaValle CT, Robien K, Cantor KP, Krasner S, Beane Freeman LE, Ward MH. Ingested nitrate, disinfection By-products, and kidney cancer risk in older women. Epidemiology. 2017;28(5):703\u201311.","journal-title":"Epidemiology"},{"issue":"1","key":"1878_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3945\/ajcn.112.043885","volume":"97","author":"AP Keszei","year":"2013","unstructured":"Keszei AP, Goldbohm RA, Schouten LJ, Jakszyn P, van den Brandt PA. Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands cohort study. Am J Clin Nutr. 2013;97(1):135\u201346.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1878_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/ijc.31055","volume":"142","author":"AJL Quist","year":"2018","unstructured":"Quist AJL, Inoue-Choi M, Weyer PJ, Anderson KE, Cantor KP, Krasner S, Freeman LEB, Ward MH, Jones RR. Ingested nitrate and nitrite, disinfection by-products, and pancreatic cancer risk in postmenopausal women. Int J Cancer. 2018;142(2):251\u201361.","journal-title":"Int J Cancer"},{"issue":"1","key":"1878_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ijc.25650","volume":"129","author":"BA Kilfoy","year":"2011","unstructured":"Kilfoy BA, Zhang Y, Park Y, Holford TR, Schatzkin A, Hollenbeck A, Ward MH. Dietary nitrate and nitrite and the risk of thyroid cancer in the NIH-AARP diet and health study. Int J Cancer. 2011;129(1):160\u201372.","journal-title":"Int J Cancer"},{"issue":"2","key":"1878_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41391-021-00413-5","volume":"25","author":"J Javier-DesLoges","year":"2022","unstructured":"Javier-DesLoges J, McKay RR, Swafford AD, Sepich-Poore GD, Knight R, Parsons JK. The Microbiome and prostate cancer. Prostate Cancer Prostatic Dis. 2022;25(2):159\u201364.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"1878_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41391-021-00480-8","volume":"25","author":"KM Chan","year":"2022","unstructured":"Chan KM, Gleadle JM, O\u2019Callaghan M, Vasilev K, MacGregor M. Prostate cancer detection: a systematic review of urinary biosensors. Prostate Cancer Prostatic Dis. 2022;25(1):39\u201346.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"1878_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41391-022-00579-6","volume":"26","author":"H Cash","year":"2023","unstructured":"Cash H, Schostak M. The role of PSA density in the MRI pathway for prostate cancer diagnostics. Prostate Cancer Prostatic Dis. 2023;26(3):437\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"3","key":"1878_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41391-022-00633-3","volume":"26","author":"JJ Tosoian","year":"2023","unstructured":"Tosoian JJ, Sessine MS, Trock BJ, Ross AE, Xie C, Zheng Y, Samora NL, Siddiqui J, Niknafs Y, Chopra Z, et al. MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. Prostate Cancer Prostatic Dis. 2023;26(3):563\u20137.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1878_CR37","doi-asserted-by":"crossref","unstructured":"Opoku Mensah B, Fondjo LA, Owiredu W, Adusei B. Urinary PCA3 a Superior Diagnostic Biomarker for Prostate Cancer among Ghanaian Men. Dis Markers 2022, 2022:1686991.","DOI":"10.1155\/2022\/1686991"},{"issue":"4","key":"1878_CR38","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/21681805.2020.1784270","volume":"54","author":"S Sforza","year":"2020","unstructured":"Sforza S, Tellini R, Grosso AA, Zaccaro C, Viola L, Di Maida F, Mari A, Carini M, Minervini A, Masieri L. Can we predict the development of symptomatic lymphocele following robot-assisted radical prostatectomy and lymph node dissection? Results from a tertiary referral centre. Scand J Urol. 2020;54(4):328\u201333.","journal-title":"Scand J Urol"},{"issue":"2","key":"1878_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/j.1439-0272.2007.00820.x","volume":"40","author":"WW Hochreiter","year":"2008","unstructured":"Hochreiter WW. The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis. Andrologia. 2008;40(2):130\u20133.","journal-title":"Andrologia"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-025-01878-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-025-01878-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T20:08:03Z","timestamp":1757362083000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-025-01878-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1878"],"URL":"https:\/\/doi.org\/10.1186\/s12894-025-01878-5","relation":{},"ISSN":["1471-2490"],"issn-type":[{"type":"electronic","value":"1471-2490"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted by following the Declaration of Helsinki, and the National Center for Health Statistics institutional review board approved the overall NHANES. This study was approved by the Institutional Review Board and documented consent was obtained from participants. Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The survey protocol was approved by the Research Ethics Review Board of the National Center for Health Statistics (), and NHANES has obtained written informed consent from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"193"}}